{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:01:50Z","timestamp":1740106910167,"version":"3.37.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"no","award":["no"],"award-info":[{"award-number":["no"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00277-022-04751-9","type":"journal-article","created":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T16:02:41Z","timestamp":1641657761000},"page":"869-880","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A fludarabine and melphalan reduced-intensity conditioning regimen for HSCT in fifteen chronic granulomatous disease patients and a literature review"],"prefix":"10.1007","volume":"101","author":[{"given":"Mohammad","family":"Vaezi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Souri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Amin","family":"Setarehdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir Ali","family":"Hamidieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1454-3933","authenticated-orcid":false,"given":"Mohammad Reza","family":"Fazlollahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Pourpak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Badalzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaghayegh","family":"Tajik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Alireza","family":"Mahdaviani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamran","family":"Alimoghaddam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ardeshir","family":"Ghavamzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,8]]},"reference":[{"issue":"10","key":"4751_CR1","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/INF.0000000000000840","volume":"34","author":"P Bortoletto","year":"2015","unstructured":"Bortoletto P, Lyman K, Camacho A, Fricchione M, Khanolkar A, Katz BZ (2015) Chronic granulomatous disease: a large, single-center US experience. Pediatr Infect Dis J 34(10):1110\u20131114","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"4751_CR2","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/blood-2016-03-704015","volume":"128","author":"B Morillo-Gutierrez","year":"2016","unstructured":"Morillo-Gutierrez B, Beier R, Rao K, Burroughs L, Schulz A, Ewins AM et al (2016) Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience. Blood 128(3):440\u2013448","journal-title":"Blood"},{"issue":"5","key":"4751_CR3","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s10875-011-9567-x","volume":"31","author":"F Fattahi","year":"2011","unstructured":"Fattahi F, Badalzadeh M, Sedighipour L, Movahedi M, Fazlollahi MR, Mansouri SD et al (2011) Inheritance pattern and clinical aspects of 93 Iranian patients with chronic granulomatous disease. J Clin Immunol 31(5):792\u2013801","journal-title":"J Clin Immunol"},{"issue":"3","key":"4751_CR4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","volume":"79","author":"JA Winkelstein","year":"2000","unstructured":"Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI et al (2000) Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79(3):155\u201369","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"4751_CR5","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1007\/s12325-017-0636-2","volume":"34","author":"DE Arnold","year":"2017","unstructured":"Arnold DE, Heimall JR (2017) A review of chronic granulomatous disease. Adv Ther 34(12):2543\u20132557","journal-title":"Adv Ther"},{"issue":"27","key":"4751_CR6","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1056\/NEJMoa1007097","volume":"363","author":"DB Kuhns","year":"2010","unstructured":"Kuhns DB, Alvord WG, Heller T, Feld JJ, Pike KM, Marciano BE et al (2010) Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 363(27):2600\u20132610","journal-title":"N Engl J Med"},{"issue":"8","key":"4751_CR7","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/cid\/ciu1154","volume":"60","author":"BE Marciano","year":"2015","unstructured":"Marciano BE, Spalding C, Fitzgerald A, Mann D, Brown T, Osgood S et al (2015) Common severe infections in chronic granulomatous disease. Clin Infect Dis 60(8):1176\u20131183","journal-title":"Clin Infect Dis"},{"issue":"1","key":"4751_CR8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s10875-012-9758-0","volume":"33","author":"T Cole","year":"2013","unstructured":"Cole T, McKendrick F, Titman P, Cant AJ, Pearce MS, Cale CM et al (2013) Health related quality of life and emotional health in children with chronic granulomatous disease: a comparison of those managed conservatively with those that have undergone haematopoietic stem cell transplant. J Clin Immunol 33(1):8\u201313","journal-title":"J Clin Immunol"},{"issue":"1","key":"4751_CR9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/MOH.0000000000000097","volume":"22","author":"A Ahlin","year":"2015","unstructured":"Ahlin A, Fasth A (2015) Chronic granulomatous disease - conventional treatment vs. hematopoietic stem cell transplantation: an update. Curr Opin Hematol. 22(1):41\u20135","journal-title":"Curr Opin Hematol."},{"issue":"9915","key":"4751_CR10","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0140-6736(13)62069-3","volume":"383","author":"T Gungor","year":"2014","unstructured":"Gungor T, Teira P, Slatter M, Stussi G, Stepensky P, Moshous D et al (2014) Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet 383(9915):436\u2013448","journal-title":"Lancet"},{"issue":"11","key":"4751_CR11","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.bbmt.2016.08.013","volume":"22","author":"P Khandelwal","year":"2016","unstructured":"Khandelwal P, Bleesing JJ, Davies SM, Marsh RA (2016) A single-center experience comparing alemtuzumab, fludarabine, and melphalan reduced-intensity conditioning with myeloablative busulfan, cyclophosphamide, and antithymocyte globulin for chronic granulomatous disease. Biol Blood Marrow Transplant 22(11):2011\u20132018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"4751_CR12","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s10875-017-0422-6","volume":"37","author":"M Parta","year":"2017","unstructured":"Parta M, Kelly C, Kwatemaa N, Theobald N, Hilligoss D, Qin J et al (2017) Allogeneic reduced-intensity hematopoietic stem cell transplantation for chronic granulomatous disease: a single-center prospective trial. J Clin Immunol 37(6):548\u2013558","journal-title":"J Clin Immunol"},{"issue":"2","key":"4751_CR13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/sj.bmt.1705923","volume":"41","author":"P Satwani","year":"2008","unstructured":"Satwani P, Cooper N, Rao K, Veys P, Amrolia P (2008) Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases. Bone Marrow Transplant 41(2):173\u2013182","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"4751_CR14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/pbc.25225","volume":"62","author":"B Oshrine","year":"2015","unstructured":"Oshrine B, Morsheimer M, Heimall J, Bunin N (2015) Reduced-intensity conditioning for hematopoietic cell transplantation of chronic granulomatous disease. Pediatr Blood Cancer 62(2):359\u2013361","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"4751_CR15","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1097\/01.TP.0000163466.73485.5E","volume":"79","author":"T Gungor","year":"2005","unstructured":"Gungor T, Halter J, Klink A, Junge S, Stumpe KD, Seger R et al (2005) Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients. Transplantation 79(11):1596\u20131606","journal-title":"Transplantation"},{"issue":"1","key":"4751_CR16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41409-018-0271-9","volume":"54","author":"T Osumi","year":"2019","unstructured":"Osumi T, Tomizawa D, Kawai T, Sako M, Inoue E, Takimoto T et al (2019) A prospective study of allogeneic transplantation from unrelated donors for chronic granulomatous disease with target busulfan-based reduced-intensity conditioning. Bone Marrow Transplant 54(1):168\u2013172","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"4751_CR17","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.bbmt.2015.04.009","volume":"21","author":"RA Marsh","year":"2015","unstructured":"Marsh RA, Rao MB, Gefen A, Bellman D, Mehta PA, Khandelwal P et al (2015) Experience with alemtuzumab, fludarabine, and melphalan reduced-intensity conditioning hematopoietic cell transplantation in patients with nonmalignant diseases reveals good outcomes and that the risk of mixed chimerism depends on underlying disease, stem cell source, and alemtuzumab regimen. Biol Blood Marrow Transplant 21(8):1460\u20131470","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"4751_CR18","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1182\/blood-2004-03-0960","volume":"105","author":"K Rao","year":"2005","unstructured":"Rao K, Amrolia PJ, Jones A, Cale CM, Naik P, King D et al (2005) Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen. Blood 105(2):879\u2013885","journal-title":"Blood"},{"issue":"1","key":"4751_CR19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jjco\/hyi211","volume":"36","author":"P Rzepecki","year":"2006","unstructured":"Rzepecki P, Sarosiek T, Szczylik C (2006) Alemtuzumab, fludarabine and melphalan as a conditioning therapy in severe aplastic anemia and hypoplastic myelodysplastic syndrome\u2014single center experience. Jpn J Clin Oncol 36(1):46\u201349","journal-title":"Jpn J Clin Oncol"},{"issue":"26","key":"4751_CR20","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1182\/blood-2010-04-282392","volume":"116","author":"RA Marsh","year":"2010","unstructured":"Marsh RA, Vaughn G, Kim MO, Li D, Jodele S, Joshi S et al (2010) Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation. Blood 116(26):5824\u20135831","journal-title":"Blood"},{"issue":"10","key":"4751_CR21","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/pbc.25113","volume":"61","author":"BR Oshrine","year":"2014","unstructured":"Oshrine BR, Olson TS, Bunin N (2014) Mixed chimerism and graft loss in pediatric recipients of an alemtuzumab-based reduced-intensity conditioning regimen for non-malignant disease. Pediatr Blood Cancer 61(10):1852\u20131859","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"4751_CR22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/bmt.2015.277","volume":"51","author":"AA Hamidieh","year":"2016","unstructured":"Hamidieh AA, Behfar M, Pourpak Z, Faghihi-Kashani S, Fazlollahi MR, Hosseini AS et al (2016) Long-term outcomes of fludarabine, melphalan and antithymocyte globulin as reduced-intensity conditioning regimen for allogeneic hematopoietic stem cell transplantation in children with primary immunodeficiency disorders: a prospective single center study. Bone Marrow Transplant 51(2):219\u2013226","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"4751_CR23","doi-asserted-by":"crossref","first-page":"e12767","DOI":"10.1111\/sji.12767","volume":"90","author":"S Tajik","year":"2019","unstructured":"Tajik S, Badalzadeh M, Fazlollahi MR, Houshmand M, Bazargan N, Movahedi M et al (2019) Genetic and molecular findings of 38 Iranian patients with chronic granulomatous disease caused by p47-phox defect. Scand J Immunol. 90(1):e12767","journal-title":"Scand J Immunol."},{"issue":"6","key":"4751_CR24","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/iji.12336","volume":"44","author":"M Badalzadeh","year":"2017","unstructured":"Badalzadeh M, Tajik S, Fazlollahi MR, Houshmand M, Fattahi F, Alizadeh Z et al (2017) Three novel mutations in CYBA among 22 Iranians with chronic granulomatous disease. Int J Immunogenet 44(6):314\u2013321","journal-title":"Int J Immunogenet"},{"issue":"8","key":"4751_CR25","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.bbmt.2008.05.005","volume":"14","author":"G Rondon","year":"2008","unstructured":"Rondon G, Saliba RM, Khouri I, Giralt S, Chan K, Jabbour E et al (2008) Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis. Biol Blood Marrow Transplant. 14(8):859\u201366","journal-title":"Biol Blood Marrow Transplant."},{"issue":"7","key":"4751_CR26","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1182\/blood-2005-08-3374","volume":"107","author":"K Fleischhauer","year":"2006","unstructured":"Fleischhauer K, Locatelli F, Zecca M, Orofino MG, Giardini C, De Stefano P et al (2006) Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction. Blood 107(7):2984\u20132992","journal-title":"Blood"},{"issue":"12","key":"4751_CR27","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 11(12):945\u201356","journal-title":"Biol Blood Marrow Transplant."},{"issue":"4","key":"4751_CR28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18(4):295\u2013304","journal-title":"Transplantation"},{"issue":"3","key":"4751_CR29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00277-002-0590-0","volume":"82","author":"I Del Giudice","year":"2003","unstructured":"Del Giudice I, Iori AP, Mengarelli A, Testi AM, Romano A, Cerretti R et al (2003) Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature. Ann Hematol 82(3):189\u2013192","journal-title":"Ann Hematol"},{"key":"4751_CR30","doi-asserted-by":"crossref","unstructured":"Chiesa R, Veys P (2012) Reduced-intensity conditioning for allogeneic stem cell transplant in primary immune deficiencies. Expert Rev Clin Immunol 8(3):255\u2013266 (quiz 67)","DOI":"10.1586\/eci.12.9"},{"issue":"1\u20133","key":"4751_CR31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12026-008-8068-3","volume":"44","author":"C Schuetz","year":"2009","unstructured":"Schuetz C, Hoenig M, Gatz S, Speth F, Benninghoff U, Schulz A et al (2009) Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease. Immunol Res 44(1\u20133):35\u201341","journal-title":"Immunol Res"},{"issue":"1","key":"4751_CR32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2141.2009.07614.x","volume":"145","author":"E Soncini","year":"2009","unstructured":"Soncini E, Slatter MA, Jones LB, Hughes S, Hodges S, Flood TJ et al (2009) Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth. Br J Haematol 145(1):73\u201383","journal-title":"Br J Haematol"},{"issue":"12","key":"4751_CR33","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1056\/NEJM200103223441203","volume":"344","author":"ME Horwitz","year":"2001","unstructured":"Horwitz ME, Barrett AJ, Brown MR, Carter CS, Childs R, Gallin JI et al (2001) Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl J Med 344(12):881\u2013888","journal-title":"N Engl J Med"},{"issue":"1","key":"4751_CR34","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12185-007-0017-8","volume":"87","author":"D Hasegawa","year":"2008","unstructured":"Hasegawa D, Fukushima M, Hosokawa Y, Takeda H, Kawasaki K, Mizukami T et al (2008) Successful treatment of chronic granulomatous disease with fludarabine-based reduced-intensity conditioning and unrelated bone marrow transplantation. Int J Hematol 87(1):88\u201390","journal-title":"Int J Hematol"},{"key":"4751_CR35","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1182\/blood.V114.22.3339.3339","volume":"114","author":"Y Mizoguchi","year":"2009","unstructured":"Mizoguchi Y, Miki M, Kajiume T, Kawaguchi H, Nakamura K, Sato T et al (2009) Effective hematopoietic stem cell transplantation with reduced intensity conditioning for patients with chronic granulomatous disease. Blood 114:3339","journal-title":"Blood"},{"issue":"4","key":"4751_CR36","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/petr.12471","volume":"19","author":"B Mehta","year":"2015","unstructured":"Mehta B, Mahadeo K, Kapoor N, Abdel-Azim H (2015) Low-dose total-body irradiation and alemtuzumab-based reduced-intensity conditioning regimen results in durable engraftment and correction of clinical disease among children with chronic granulomatous disease. Pediatr Transplant 19(4):408\u2013412","journal-title":"Pediatr Transplant"},{"issue":"Suppl 1","key":"4751_CR37","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.3345\/kjp.2016.59.11.S57","volume":"59","author":"HY Ju","year":"2016","unstructured":"Ju HY, Kang HJ, Hong CR, Lee JW, Kim H, Song SH et al (2016) Targeted busulfan and fludarabine-based conditioning for bone marrow transplantation in chronic granulomatous disease. Korean J Pediatr 59(Suppl 1):S57\u2013S59","journal-title":"Korean J Pediatr"},{"issue":"3","key":"4751_CR38","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1016\/j.bbmt.2016.12.449","volume":"23","author":"S Bhatt","year":"2017","unstructured":"Bhatt S, Schulz G, Hente M, Murray L, Shenoy S, Bednarski JJ (2017) A single center experience using alemtuzumab, fludarabine, melphalan and thiotepa as conditioning for transplant in chronic granulomatous disease. Biol Blood Marrow Transplant 23(3):S227","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"4751_CR39","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.1016\/j.bbmt.2016.12.456","volume":"23","author":"JF Fernandes","year":"2017","unstructured":"Fernandes JF, Mantovani LFAL, Venancio AM, Dorna M, Pastorino AC, Vasconcelos D et al (2017) Hematopoietic stem cell transplantation for chronic granulomatous disease in a single institution in Brazil. Reproducing Good Results with a Reduced Toxicity Regimen. Biol Blood Marrow Transplant 23(3):S231","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1 Suppl","key":"4751_CR40","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.bbmt.2010.09.008","volume":"17","author":"BH Segal","year":"2011","unstructured":"Segal BH, Veys P, Malech H, Cowan MJ (2011) Chronic granulomatous disease: lessons from a rare disorder. Biol Blood Marrow Transplant 17(1 Suppl):S123\u2013S131","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"4751_CR41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s10875-014-0113-5","volume":"35","author":"T Shigemura","year":"2015","unstructured":"Shigemura T, Nakazawa Y, Hirabayashi K, Kobayashi N, Sakashita K, Agematsu K et al (2015) Dramatic improvement in the multifocal positron emission tomography findings of a young adult with chronic granulomatous disease following allogeneic hematopoietic stem cell transplantation. J Clin Immunol 35(1):84\u201386","journal-title":"J Clin Immunol"},{"key":"4751_CR42","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1749-6632.2011.06243.x","volume":"1238","author":"MA Slatter","year":"2011","unstructured":"Slatter MA, Cant AJ (2011) Hematopoietic stem cell transplantation for primary immunodeficiency diseases. Ann N Y Acad Sci 1238:122\u2013131","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"4751_CR43","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/j.1365-2141.2008.07533.x","volume":"144","author":"M Lawler","year":"2009","unstructured":"Lawler M, McCann SR, Marsh JC et al (2009) Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA. Br J Haematol 144(6):933\u2013945. https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07533.x","journal-title":"Br J Haematol"},{"issue":"5","key":"4751_CR44","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.bbmt.2015.01.016","volume":"21","author":"C Calmettes","year":"2015","unstructured":"Calmettes C, Vigouroux S, Labopin M et al (2015) Risk factors for steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation from matched related or unrelated donors. Biol Blood Marrow Transplant 21(5):860\u2013865. https:\/\/doi.org\/10.1016\/j.bbmt.2015.01.016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"4751_CR45","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.bbmt.2013.02.015","volume":"19","author":"A Stikvoort","year":"2013","unstructured":"Stikvoort A, Gertow J, Sundin M, Remberger M, Mattsson J, Uhlin M (2013) Chimerism patterns of long-term stable mixed chimeras posthematopoietic stem cell transplantation in patients with nonmalignant diseases: follow-up of long-term stable mixed chimerism patients. Biol Blood Marrow Transplant 19(5):838\u2013844","journal-title":"Biol Blood Marrow Transplant"},{"issue":"19","key":"4751_CR46","doi-asserted-by":"crossref","first-page":"27255","DOI":"10.18632\/oncotarget.8463","volume":"7","author":"T Czerw","year":"2016","unstructured":"Czerw T, Labopin M, Schmid C, Cornelissen JJ, Chevallier P, Blaise D et al (2016) High CD3+ and CD34+ peripheral blood stem cell grafts content is associated with increased risk of graft-versus-host disease without beneficial effect on disease control after reduced-intensity conditioning allogeneic transplantation from matched unrelated donors for acute myeloid leukemia \u2014 an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Oncotarget 7(19):27255\u201327266","journal-title":"Oncotarget"},{"issue":"4","key":"4751_CR47","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/sj.bmt.1705913","volume":"41","author":"M Remberger","year":"2008","unstructured":"Remberger M, Mattsson J, Hassan Z, Karlsson N, LeBlanc K, Omazic B et al (2008) Risk factors for acute graft-versus-host disease grades II-IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors: a single centre study. Bone Marrow Transplant 41(4):399\u2013405","journal-title":"Bone Marrow Transplant"},{"issue":"13","key":"4751_CR48","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1182\/blood-2002-02-0583","volume":"100","author":"RA Seger","year":"2002","unstructured":"Seger RA, Gungor T, Belohradsky BH, Blanche S, Bordigoni P, Di Bartolomeo P et al (2002) Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985\u20132000. Blood 100(13):4344\u20134350","journal-title":"Blood"},{"issue":"Suppl 1","key":"4751_CR49","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1182\/blood.V130.Suppl_1.671.671","volume":"130","author":"J Yonkof","year":"2017","unstructured":"Yonkof J, Gupta AO, Fu P, Garabedian E, Dalal JD (2017) Early transplant improves outcomes in patients with chronic granulomatous disease: results from United States Immunodeficiency Network (USIDNET). Blood 130(Suppl 1):671\u2013671","journal-title":"Blood"},{"issue":"11","key":"4751_CR50","first-page":"1087","volume":"102","author":"A Ahlin","year":"2013","unstructured":"Ahlin A, Fugelang J, de Boer M, Ringden O, Fasth A, Winiarski J (2013) Chronic granulomatous disease-haematopoietic stem cell transplantation versus conventional treatment. Acta Paediatr 102(11):1087\u20131094","journal-title":"Acta Paediatr"},{"key":"4751_CR51","unstructured":"European Blood and Marrow Transplantation\/European Society for Immunodeficiencies HSCT Guidelines. Available at: https:\/\/www.ebmt.org\/ebmt\/documents\/esid-ebmt-hsct-guidelines-2017. Accessed 11 Jan 2020"},{"issue":"suppl_1","key":"4751_CR52","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1093\/jpids\/piy015","volume":"7","author":"JA Connelly","year":"2018","unstructured":"Connelly JA, Marsh R, Parikh S, Talano JA (2018) Allogeneic hematopoietic cell transplantation for chronic granulomatous disease: controversies and state of the art. J Pediatric Infect Dis Soc 7(suppl_1):S31-s9","journal-title":"J Pediatric Infect Dis Soc"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04751-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-022-04751-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04751-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T12:07:42Z","timestamp":1646914062000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-022-04751-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,8]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["4751"],"URL":"https:\/\/doi.org\/10.1007\/s00277-022-04751-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2022,1,8]]},"assertion":[{"value":"4 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}